206 related articles for article (PubMed ID: 33433435)
21. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
22. Comparison between adenocarcinoma in both endocervical and endometrial specimens from fractional curettage and pathologic findings in subsequent hysterectomy specimens.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2008 Sep; 91(9):1313-7. PubMed ID: 18843857
[TBL] [Abstract][Full Text] [Related]
23. Expression and clinical significance of a new neuroendocrine marker secretagogin in cervical neuroendocrine carcinoma.
Yu L; Suye S; Huang R; Liang Q; Fu C
J Clin Pathol; 2021 Dec; 74(12):787-795. PubMed ID: 33060116
[TBL] [Abstract][Full Text] [Related]
24. Large cell neuroendocrine carcinoma of the uterine cervix with cytogenetic analysis by comparative genomic hybridization: a case study.
Kawauchi S; Okuda S; Morioka H; Iwasaki F; Fukuma F; Chochi Y; Furuya T; Oga A; Sasaki K
Hum Pathol; 2005 Oct; 36(10):1096-100. PubMed ID: 16226109
[TBL] [Abstract][Full Text] [Related]
25. Small cell carcinoma of the uterine cervix with large cell neuroendocrine carcinoma component.
Tsou MH; Tan TD; Cheng SH; Chiou YK
Gynecol Oncol; 1998 Jan; 68(1):69-72. PubMed ID: 9454664
[TBL] [Abstract][Full Text] [Related]
26. Endocrine cell hyperplasia of the uterine cervix. A precursor of neuroendocrine carcinoma of the cervix?
Chan JK; Tsui WM; Tung SY; Ching RC
Am J Clin Pathol; 1989 Dec; 92(6):825-30. PubMed ID: 2556022
[TBL] [Abstract][Full Text] [Related]
27. Invasive Micropapillary Carcinoma of the Uterine Cervix: Case Report of a Rare Entity.
Munakata S; Hosoi A; Yamamoto T
Int J Gynecol Pathol; 2018 Jul; 37(4):368-371. PubMed ID: 28787322
[TBL] [Abstract][Full Text] [Related]
28. Minimal-deviation Endometrioid Adenocarcinoma of the Cervix: A Case Report With Ultrastructural Analysis Demonstrating Abnormal Ciliation of the Tumor Cells.
Gould PR; Stewart CJR; Papadimitriou JM
Int J Gynecol Pathol; 2017 Jan; 36(1):90-94. PubMed ID: 27362904
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix.
Zhu R; Wu H; Chen B; Pang J; Huo Z
Diagn Pathol; 2019 Jun; 14(1):64. PubMed ID: 31228945
[TBL] [Abstract][Full Text] [Related]
30. Monoclonality of composite large-cell neuroendocrine carcinoma and invasive intestinal-type mucinous adenocarcinoma of the cervix: a case study.
Yasuoka H; Tsujimoto M; Ueda M; Kodama R; Iwahashi Y; Inagaki M; Mabuchi Y; Ino K; Sanke T; Nakamura Y
Int J Gynecol Pathol; 2013 Jul; 32(4):416-20. PubMed ID: 23722515
[TBL] [Abstract][Full Text] [Related]
31. CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.
Uehara K; Ikehara F; Tanabe Y; Nakazato I; Oshiro M; Inamine M; Kinjo T
Diagn Pathol; 2016 Feb; 11():16. PubMed ID: 26830028
[TBL] [Abstract][Full Text] [Related]
32. Endocervicosis of the Uterine Cervix.
Mobarki M; Karpathiou G; Forest F; Corsini T; Peoc'h M
Int J Gynecol Pathol; 2016 Sep; 35(5):475-7. PubMed ID: 26825004
[TBL] [Abstract][Full Text] [Related]
33. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
34. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
35. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
36. Distribution of Neuroendocrine Marker-Positive Cells in Colorectal Cancer Tissue and Normal Mucosal Tissue: Consideration of Histogenesis of Neuroendocrine Cancer.
Ogimi T; Sadahiro S; Kamei Y; Chan LF; Miyakita H; Saito G; Okada K; Suzuki T; Kajiwara H
Oncology; 2019; 97(5):294-300. PubMed ID: 31390635
[TBL] [Abstract][Full Text] [Related]
37. Tracheloscopically directed biopsy of the endocervical canal in stage II adenocarcinomas of the endometrium.
Edinger DD; Jelen I; Granai C; Anderson B
Eur J Gynaecol Oncol; 1983; 4(1):6-8. PubMed ID: 6861779
[TBL] [Abstract][Full Text] [Related]
38. Triple composite tumor of stomach: a rare combination of alpha fetoprotein positive hepatoid adenocarcinoma, tubular adenocarcinoma and large cell neuroendocrine carcinoma.
Lipi L; Sachdev R; Gautam D; Singh J; Mohapatra I
Indian J Pathol Microbiol; 2014; 57(1):98-100. PubMed ID: 24739843
[TBL] [Abstract][Full Text] [Related]
39. Complete Response to Combination Nivolumab and Ipilimumab in Recurrent Neuroendocrine Carcinoma of the Cervix.
Paterniti TA; Dorr K; Ullah A; White J; Williams H; Ghamande S
Obstet Gynecol; 2021 Nov; 138(5):813-816. PubMed ID: 34619736
[TBL] [Abstract][Full Text] [Related]
40. Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix.
Kuji S; Endo A; Kubota M; Uekawa A; Kawakami F; Mikami Y; Koike J; Suzuki N
J Gynecol Oncol; 2023 Jan; 34(1):e1. PubMed ID: 36245222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
